Cigna Group Past Earnings Performance
Past criteria checks 1/6
Cigna Group has been growing earnings at an average annual rate of 8.9%, while the Healthcare industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 13.4% per year. Cigna Group's return on equity is 11.6%, and it has net margins of 2.6%.
Key information
8.9%
Earnings growth rate
11.1%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 13.4% |
| Return on equity | 11.6% |
| Net Margin | 2.6% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cigna Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 195,187 | 5,164 | 14,370 | 0 |
| 30 Sep 23 | 189,856 | 5,292 | 14,062 | 0 |
| 30 Jun 23 | 186,021 | 6,641 | 13,621 | 0 |
| 31 Mar 23 | 182,798 | 6,738 | 13,433 | 0 |
| 31 Dec 22 | 180,031 | 6,704 | 13,110 | 0 |
| 30 Sep 22 | 180,028 | 6,627 | 13,042 | 0 |
| 30 Jun 22 | 179,185 | 5,491 | 12,999 | 0 |
| 31 Mar 22 | 176,986 | 5,401 | 12,748 | 0 |
| 31 Dec 21 | 174,267 | 5,370 | 12,791 | 0 |
| 30 Sep 21 | 170,397 | 8,384 | 13,296 | 0 |
| 30 Jun 21 | 167,028 | 8,151 | 13,402 | 0 |
| 31 Mar 21 | 163,141 | 8,438 | 13,697 | 0 |
| 31 Dec 20 | 160,550 | 8,458 | 13,660 | 0 |
| 30 Sep 20 | 157,009 | 5,300 | 13,329 | 0 |
| 30 Jun 20 | 154,629 | 5,263 | 13,467 | 0 |
| 31 Mar 20 | 154,168 | 4,917 | 13,332 | 0 |
| 31 Dec 19 | 153,743 | 5,104 | 13,315 | 0 |
| 30 Sep 19 | 129,660 | 4,271 | 12,391 | 0 |
| 30 Jun 19 | 102,510 | 3,692 | 12,107 | 0 |
| 31 Mar 19 | 75,145 | 3,090 | 11,651 | 0 |
| 31 Dec 18 | 48,569 | 2,637 | 11,141 | 0 |
| 30 Sep 18 | 44,969 | 2,759 | 18,350 | 0 |
| 30 Jun 18 | 44,001 | 2,547 | 15,343 | 0 |
| 31 Mar 18 | 42,949 | 2,554 | 12,639 | 0 |
| 31 Dec 17 | 42,043 | 2,237 | 9,830 | 0 |
| 30 Sep 17 | 41,332 | 2,353 | 54 | 0 |
| 30 Jun 17 | 40,723 | 2,249 | 0 | 0 |
| 31 Mar 17 | 40,258 | 1,946 | 0 | 0 |
| 31 Dec 16 | 40,007 | 1,867 | 9,750 | 0 |
| 30 Sep 16 | 39,252 | 1,911 | 0 | 0 |
| 30 Jun 16 | 38,761 | 2,002 | 0 | 0 |
| 31 Mar 16 | 38,293 | 2,080 | 0 | 0 |
| 31 Dec 15 | 37,876 | 2,094 | 0 | 0 |
| 30 Sep 15 | 37,276 | 2,135 | 0 | 0 |
| 30 Jun 15 | 36,644 | 2,122 | 0 | 0 |
| 31 Mar 15 | 35,885 | 2,107 | 0 | 0 |
| 31 Dec 14 | 34,914 | 2,102 | 0 | 0 |
| 30 Sep 14 | 34,098 | 1,996 | 0 | 0 |
| 30 Jun 14 | 33,407 | 2,015 | 0 | 0 |
| 31 Mar 14 | 32,654 | 1,947 | 0 | 0 |
| 31 Dec 13 | 32,380 | 1,476 | 0 | 0 |
| 30 Sep 13 | 31,888 | 1,521 | 0 | 0 |
| 30 Jun 13 | 31,145 | 1,434 | 0 | 0 |
Quality Earnings: CGN has a large one-off loss of $2.0B impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: CGN's current net profit margins (2.6%) are lower than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CGN's earnings have grown by 8.9% per year over the past 5 years.
Accelerating Growth: CGN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CGN had negative earnings growth (-23%) over the past year, making it difficult to compare to the Healthcare industry average (-7.5%).
Return on Equity
High ROE: CGN's Return on Equity (11.6%) is considered low.